Published on : Jan 08, 2018
ALBANY, New York, Jan 08, 2018: ResearchMoz.us has announced the addition of a report, titled “Global Infertility Treatment Market Analysis By Procedure (ART, Artificial Insemination, Fertility Surgery, Fertility Drugs, Others), Establishment (Fertility Clinics, Hospitals, Research Banks), By Region, By Country (2012-2022)”, to its repository. The comprehensive study on the global infertility treatment market offers in-depth evaluation of key growth dynamics, notable trends impacting current and emerging opportunities, factors driving the demand for procedures.
The report offers an insight into the current market scope, potential of emerging technologies, share and size of key segments, and competitive landscape in regions such as North America, Europe, and Asia Pacific (APAC). The study takes a closer look at regulatory landscape prevailing in countries such as the U.S., Canada, Germany, the U.K., France, India, UAE, China, and Brazil and their impact on the overall growth trajectory. The global market is estimated to rise at an impressive CAGR of 8.25% from 2017 to 2022. Favorable governmental reforms in recent years and the constant development of new and improved technologies and procedures in the market are opening up new prospects accentuating the growth through the assessment period.
The drive for infertility treatment stems from the growing cases of infertility, infecundity, and childlessness world over, especially among women. The prevalence of infertility is on the rise in several developed nations, such as the U.S., the U.K., and Canada, which has stoked the demand for treatments. The rising awareness of infertility among demographics in various developing economies is also boosting the global infertility treatment market over the forecast period. A number of awareness campaigns by government has provided a robust impetus to the growth of the market. Furthermore, the growing share of disposal incomes in emerging economies also bodes well for the market.
Get SAMPLE REPORT PDF: https://www.researchmoz.us/enquiry.php?type=S&repid=1422693
The rising number of infertility clinics in several developing and developed nations, coupled with a substantially growing public-private funds and grants, is a notable factor boosting the market. The growing demand for infertility treatment by single parents and same-sex couples is a notable trend expected to accentuate the market in the years to come.
However, various concerns related to assisted reproductive technologies (ART) are adversely affecting the growth of the market to an extent. Nevertheless, Constant advances in in vitro fertilization procedures in various developed nations are improving the clinical outcome of the procedure, and have positively impacting the growth of the market in recent years. In addition, a booming medical tourism in a number of developing and developed economies is expected to open up abundant opportunities to market players over the assessment period. A declining cost of treatment and promising clinical outcomes of procedures in these regions are key factors contributing to the growth of the market.
Of the various regions, Europe is projected to rise at the leading growth rate. The growth will be fuelled by an extensive uptake of ART techniques, a burgeoning medical tourism in the U.K., and prevailing favorable regulatory scenario in various parts of the region. In addition, a robust healthcare infrastructure in the region is also accentuating the growth. Improving healthcare infrastructures in various developing markets also bodes well for the market.
Major procedures in infertility treatment are Artificial Insemination, ART, Fertility Surgery, and Fertility Drugs. Various ART procedures are IVF and intracytoplasmic sperm injection (ICSI). Various establishments for the infertility treatment are fertility clinics, hospitals, and research banks.
Key players operating in the infertility treatment market are Ferring Pharmaceutical SA, Merck &Co, United Healthcare Group, Monash IVF Group, Thermo Fisher, and the Cooper Company.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on [email protected]